Free Trial

Butterfly Network (NYSE:BFLY) Trading 8.9% Higher - Here's What Happened

Butterfly Network logo with Medical background

Butterfly Network, Inc. (NYSE:BFLY - Get Free Report) shot up 8.9% on Wednesday . The stock traded as high as $3.69 and last traded at $3.67. 1,660,728 shares were traded during trading, a decline of 67% from the average session volume of 5,022,959 shares. The stock had previously closed at $3.37.

Butterfly Network Price Performance

The firm has a market capitalization of $782.14 million, a PE ratio of -7.98 and a beta of 2.45. The business has a 50-day simple moving average of $3.32 and a 200-day simple moving average of $2.09.

Butterfly Network (NYSE:BFLY - Get Free Report) last posted its quarterly earnings data on Friday, November 1st. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01. The company had revenue of $20.56 million during the quarter, compared to analyst estimates of $19.12 million. Butterfly Network had a negative net margin of 129.25% and a negative return on equity of 42.68%. During the same period in the previous year, the firm earned ($0.13) earnings per share. On average, research analysts expect that Butterfly Network, Inc. will post -0.34 earnings per share for the current year.

Insider Activity at Butterfly Network

In related news, CFO Heather C. Getz sold 30,136 shares of the company's stock in a transaction dated Friday, December 20th. The shares were sold at an average price of $3.06, for a total value of $92,216.16. Following the completion of the sale, the chief financial officer now directly owns 2,669,333 shares of the company's stock, valued at $8,168,158.98. This represents a 1.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Steve Cashman sold 164,079 shares of the stock in a transaction that occurred on Friday, December 20th. The shares were sold at an average price of $3.06, for a total transaction of $502,081.74. Following the transaction, the insider now owns 1,835,921 shares in the company, valued at approximately $5,617,918.26. This represents a 8.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 27.28% of the stock is owned by company insiders.

Hedge Funds Weigh In On Butterfly Network

A number of large investors have recently bought and sold shares of the business. Marshall Wace LLP boosted its position in Butterfly Network by 353.7% during the 2nd quarter. Marshall Wace LLP now owns 318,383 shares of the company's stock valued at $267,000 after acquiring an additional 248,201 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. lifted its stake in shares of Butterfly Network by 1,045.0% during the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 256,974 shares of the company's stock worth $216,000 after purchasing an additional 234,530 shares during the last quarter. XTX Topco Ltd boosted its position in Butterfly Network by 169.7% during the third quarter. XTX Topco Ltd now owns 360,392 shares of the company's stock valued at $638,000 after purchasing an additional 226,781 shares in the last quarter. Renaissance Technologies LLC grew its stake in Butterfly Network by 46.5% in the second quarter. Renaissance Technologies LLC now owns 343,100 shares of the company's stock valued at $288,000 after purchasing an additional 108,944 shares during the last quarter. Finally, Cubist Systematic Strategies LLC purchased a new position in Butterfly Network in the second quarter valued at about $90,000. Institutional investors own 37.85% of the company's stock.

Butterfly Network Company Profile

(Get Free Report)

Butterfly Network, Inc develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Butterfly Network Right Now?

Before you consider Butterfly Network, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Butterfly Network wasn't on the list.

While Butterfly Network currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines